دورية أكاديمية
Microparticles in the Development and Improvement of Pharmaceutical Formulations: An Analysis of In Vitro and In Vivo Studies.
| العنوان: | Microparticles in the Development and Improvement of Pharmaceutical Formulations: An Analysis of In Vitro and In Vivo Studies. |
|---|---|
| المؤلفون: | da Silva RYP; Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil., de Menezes DLB; Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil., Oliveira VDS; Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil., Converti A; Department of Civil, Chemical and Environment Engineering, Pole of Chemical Engineering, University of Genoa, I-16145 Genoa, Italy., de Lima ÁAN; Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil. |
| المصدر: | International journal of molecular sciences [Int J Mol Sci] 2023 Mar 13; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 13. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI, [2000- |
| مواضيع طبية MeSH: | Drug Delivery Systems*/methods , Polymers*/chemistry, Drug Compounding/methods ; Excipients ; Capsules ; Microspheres ; Particle Size |
| مستخلص: | Microparticulate systems such as microparticles, microspheres, microcapsules or any particle in a micrometer scale (usually of 1-1000 µm) are widely used as drug delivery systems, because they offer higher therapeutic and diagnostic performance compared to conventional drug delivery forms. These systems can be manufactured with many raw materials, especially polymers, most of which have been effective in improving the physicochemical properties and biological activities of active compounds. This review will focus on the in vivo and in vitro application in the last decade (2012 to 2022) of different active pharmaceutical ingredients microencapsulated in polymeric or lipid matrices, the main formulation factors (excipients and techniques) and mostly their biological activities, with the aim of introducing and discussing the potential applicability of microparticulate systems in the pharmaceutical field. |
| References: | Antimicrob Agents Chemother. 2018 Feb 23;62(3):. (PMID: 29263064) Eur J Pharm Biopharm. 2017 Oct;119:17-27. (PMID: 28461085) Acta Pharm Sin B. 2017 Jan;7(1):80-90. (PMID: 28119812) J Control Release. 2016 Nov 10;241:110-124. (PMID: 27663228) J Trop Med. 2020 Apr 30;2020:5278518. (PMID: 32411255) Mater Sci Eng C Mater Biol Appl. 2021 Sep;128:112275. (PMID: 34474834) Eur J Pharm Sci. 2019 Apr 1;131:167-176. (PMID: 30790703) Int J Pharm. 2020 Sep 25;587:119700. (PMID: 32738457) Eur J Med Chem. 2019 Sep 15;178:687-704. (PMID: 31228811) Mater Sci Eng C Mater Biol Appl. 2019 Sep;102:113-123. (PMID: 31146981) Biomaterials. 2016 Dec;110:71-80. (PMID: 27710834) Int J Pharm. 2019 Oct 5;569:118578. (PMID: 31362096) Biomaterials. 2009 May;30(13):2440-8. (PMID: 19215978) Eur J Clin Pharmacol. 1988;33 Suppl:S15-8. (PMID: 3371389) Curr Pharm Des. 2021;27(19):2289-2298. (PMID: 33081675) Biomaterials. 2020 Jan;228:119575. (PMID: 31677394) Parasitol Int. 2016 Apr;65(2):99-104. (PMID: 26518128) Expert Opin Drug Deliv. 2015 May;12(5):763-77. (PMID: 25516397) Microb Pathog. 2016 Jun;95:32-42. (PMID: 26911646) Environ Sci Pollut Res Int. 2020 Jun;27(16):19151-19168. (PMID: 31079299) Carbohydr Polym. 2019 May 15;212:430-438. (PMID: 30832877) Acta Biomater. 2013 Mar;9(3):5583-9. (PMID: 23153760) Drug Deliv. 2019 Dec;26(1):1206-1221. (PMID: 31746243) Indian J Cancer. 2010 Oct-Dec;47(4):458-68. (PMID: 21131762) Int J Pharm. 2020 Apr 15;579:119175. (PMID: 32109541) Int J Parasitol Drugs Drug Resist. 2019 Dec;11:148-155. (PMID: 31331828) PLoS One. 2017 Jul 28;12(7):e0182381. (PMID: 28753648) ACS Appl Mater Interfaces. 2020 Oct 21;12(42):47278-47288. (PMID: 32990431) Pharmaceutics. 2020 Jan 22;12(2):. (PMID: 31979138) Appl Environ Microbiol. 2020 Sep 1;86(18):. (PMID: 32651210) Int J Pharm. 2022 Nov 25;628:122327. (PMID: 36280218) Eur J Pharmacol. 2020 Jan 5;866:172804. (PMID: 31738938) Microbes Infect. 2022 Mar;24(2):104884. (PMID: 34487860) Colloids Surf B Biointerfaces. 2019 Aug 1;180:127-140. (PMID: 31035056) J Appl Microbiol. 2017 Nov;123(5):1346-1358. (PMID: 28815882) Biomaterials. 2013 Sep;34(27):6444-53. (PMID: 23755831) Int J Mol Sci. 2014 Mar 18;15(3):4795-822. (PMID: 24646916) Molecules. 2019 Apr 17;24(8):. (PMID: 30999569) Micromachines (Basel). 2020 Feb 01;11(2):. (PMID: 32024165) Int J Mol Sci. 2022 Oct 11;23(20):. (PMID: 36292962) Acta Biomater. 2022 Sep 1;149:347-358. (PMID: 35779774) Int J Pharm. 2013 Nov 30;457(1):82-91. (PMID: 24075861) Diabetes Care. 2008 Nov;31(11):2177-82. (PMID: 18678610) Pharm Dev Technol. 2017 Feb;22(1):63-68. (PMID: 27055726) J Pharm Sci. 2019 Oct;108(10):3348-3358. (PMID: 31103789) Ultrason Sonochem. 2018 Jan;40(Pt A):686-696. (PMID: 28946474) Int J Mol Sci. 2021 Aug 16;22(16):. (PMID: 34445466) Pharmacol Res. 2017 Jul;121:158-168. (PMID: 28414177) Anesth Analg. 2007 Jul;105(1):176-83. (PMID: 17578973) Clin Ther. 2002 Nov;24(11):1902-14. (PMID: 12501882) J Control Release. 2020 Apr 10;320:265-282. (PMID: 31962095) Eur J Pharm Biopharm. 2020 Jun;151:61-72. (PMID: 32283213) Diabetes Care. 2015 Dec;38(12):2266-73. (PMID: 26180109) ACS Appl Mater Interfaces. 2020 Feb 19;12(7):8030-8039. (PMID: 32013379) Diabetes Care. 2007 Sep;30(9):2307-8. (PMID: 17586744) Drug Dev Ind Pharm. 2019 Aug;45(8):1313-1320. (PMID: 30990096) PLoS One. 2014 Mar 21;9(3):e92723. (PMID: 24658463) Colloids Surf B Biointerfaces. 2015 Feb 1;126:50-7. (PMID: 25543983) Colloids Surf B Biointerfaces. 2014 Oct 1;122:498-504. (PMID: 25082753) Int J Biol Macromol. 2020 Apr 23;158:922-936. (PMID: 32335117) Front Immunol. 2018 Dec 04;9:2851. (PMID: 30564244) Eur J Pharm Biopharm. 2014 Feb;86(2):292-300. (PMID: 24211657) Molecules. 2019 May 10;24(9):. (PMID: 31083306) Biomed Pharmacother. 2019 Mar;111:1046-1056. (PMID: 30841418) J Microencapsul. 2016 Dec;33(8):735-742. (PMID: 27841060) Int J Pharm. 2014 Mar 10;463(1):10-21. (PMID: 24406672) Ann Pharmacother. 2010 Jul-Aug;44(7-8):1231-9. (PMID: 20516362) Parasitology. 2020 Aug;147(9):1032-1037. (PMID: 32364107) Int J Pharm. 2016 Feb 29;499(1-2):186-194. (PMID: 26768723) Int J Biol Macromol. 2022 Nov 1;220:348-359. (PMID: 35981679) Eur J Pharm Sci. 2017 Jan 1;96:390-397. (PMID: 27721042) Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:160-167. (PMID: 28024572) Trop Med Int Health. 2005 Jun;10(6):530-6. (PMID: 15941415) Oxid Med Cell Longev. 2016;2016:9130976. (PMID: 28044094) Carbohydr Polym. 2020 Nov 1;247:116550. (PMID: 32829783) Colloids Surf B Biointerfaces. 2013 Jul 1;107:235-44. (PMID: 23502046) J Microbiol Methods. 2019 Jul;162:1-7. (PMID: 31078626) Saudi Pharm J. 2016 Jul;24(4):458-72. (PMID: 27330377) J Pharm Sci. 2018 Dec;107(12):3060-3069. (PMID: 30098991) Pharmaceutics. 2020 Jan 03;12(1):. (PMID: 31947874) J Aerosol Med Pulm Drug Deliv. 2018 Dec;31(6):347-357. (PMID: 29877747) Eur J Clin Pharmacol. 1988;33 Suppl:S45-9. (PMID: 3371394) J Control Release. 2015 Jul 10;209:229-37. (PMID: 25956458) Int J Pharm. 2020 May 30;582:119350. (PMID: 32315747) Mater Sci Eng C Mater Biol Appl. 2013 Jul 1;33(5):2958-66. (PMID: 23623119) J Pharm Sci. 2015 Mar;104(3):872-905. (PMID: 25546108) Med Res Rev. 2019 Nov;39(6):2343-2396. (PMID: 31004359) Int J Mol Sci. 2022 Sep 01;23(17):. (PMID: 36077367) Saudi Pharm J. 2015 Sep;23(4):429-36. (PMID: 27134546) J Control Release. 2016 Jul 10;233:72-80. (PMID: 27151077) Clin Ther. 2010 Apr;32(4):744-57. (PMID: 20435244) Mol Pharm. 2013 Mar 4;10(3):1045-55. (PMID: 23320733) Curr Drug Deliv. 2018;15(7):953-964. (PMID: 29446743) Diabetes Technol Ther. 2011 Dec;13(12):1201-6. (PMID: 21999640) Prog Lipid Res. 2002 Sep;41(5):392-406. (PMID: 12121719) |
| معلومات مُعتمدة: | 01 Coordenação de Aperfeicoamento de Pessoal de Nível Superior |
| فهرسة مساهمة: | Keywords: biological activity; drug delivery systems; in vitro assay; in vivo assay; polymeric microparticles |
| المشرفين على المادة: | 0 (Polymers) 0 (Excipients) 0 (Capsules) |
| تواريخ الأحداث: | Date Created: 20230329 Date Completed: 20230330 Latest Revision: 20230331 |
| رمز التحديث: | 20230331 |
| مُعرف محوري في PubMed: | PMC10049314 |
| DOI: | 10.3390/ijms24065441 |
| PMID: | 36982517 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1422-0067 |
|---|---|
| DOI: | 10.3390/ijms24065441 |